Iovance Biotherapeutics Inc (IOVA)
8.88
-0.12
(-1.33%)
USD |
NASDAQ |
May 31, 16:00
8.89
+0.01
(+0.11%)
After-Hours: 20:00
Iovance Biotherapeutics 1 Year Total Returns (Daily): 1.60% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 31, 2024 | 1.60% |
May 30, 2024 | 1.69% |
May 29, 2024 | 22.91% |
May 28, 2024 | 28.48% |
May 24, 2024 | 24.04% |
May 23, 2024 | 13.24% |
May 22, 2024 | 29.29% |
May 21, 2024 | 40.22% |
May 20, 2024 | 40.62% |
May 17, 2024 | 36.53% |
May 16, 2024 | 39.25% |
May 15, 2024 | 36.22% |
May 14, 2024 | 43.51% |
May 13, 2024 | 45.65% |
May 10, 2024 | 43.52% |
May 09, 2024 | 82.74% |
May 08, 2024 | 89.12% |
May 07, 2024 | 104.1% |
May 06, 2024 | 102.6% |
May 03, 2024 | 108.7% |
May 02, 2024 | 110.1% |
May 01, 2024 | 94.40% |
April 30, 2024 | 108.9% |
April 29, 2024 | 113.3% |
April 26, 2024 | 112.8% |
Date | Value |
---|---|
April 25, 2024 | 109.4% |
April 24, 2024 | 105.4% |
April 23, 2024 | 107.7% |
April 22, 2024 | 98.25% |
April 19, 2024 | 93.33% |
April 18, 2024 | 106.3% |
April 17, 2024 | 103.1% |
April 16, 2024 | 111.3% |
April 15, 2024 | 110.8% |
April 12, 2024 | 129.7% |
April 11, 2024 | 139.8% |
April 10, 2024 | 125.4% |
April 09, 2024 | 122.9% |
April 08, 2024 | 120.4% |
April 05, 2024 | 130.5% |
April 04, 2024 | 129.7% |
April 03, 2024 | 123.1% |
April 02, 2024 | 125.4% |
April 01, 2024 | 132.2% |
March 28, 2024 | 138.6% |
March 27, 2024 | 129.3% |
March 26, 2024 | 154.1% |
March 25, 2024 | 162.7% |
March 22, 2024 | 153.3% |
March 21, 2024 | 144.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-72.14%
Minimum
Jan 19 2022
284.3%
Maximum
Dec 23 2019
17.87%
Average
-11.05%
Median
Mar 05 2021
1 Year Total Returns (Daily) Benchmarks
Viatris Inc | 21.14% |
Beam Therapeutics Inc | -25.33% |
Revolution Medicines Inc | 53.75% |
Day One Biopharmaceuticals Inc | -0.23% |
Viking Therapeutics Inc | 183.7% |